Back
Akero Therapeutics Stock Price Chart
Sponsored
AKRO
Sponsored
Here's precisely how to capitalize on a booming copper market in 2025
Don't miss the free report.
Buy
57
AKRO
Akero Therapeutics
Last Price:
$55.30
Seasonality Move:
-13.54%
7 Day Trial
ALL ACCESS PASS
$
7
Pulling an Uber in the $500 Billion Smartphone Industry
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.66 | Buy |
20-day SMA: | 29.67 | Buy |
50-day SMA: | 29.97 | Buy |
200-day SMA: | 26.38 | Buy |
8-day EMA: | 39.78 | Buy |
20-day EMA: | 32.93 | Buy |
50-day EMA: | 30.49 | Buy |
200-day EMA: | 28.24 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.24 | Buy |
Relative Strength Index (14 RSI): | 85.85 | Buy |
Chaikin Money Flow: | 423269 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.76 - 38.18) | Buy |
Bollinger Bands (100): | (24.88 - 34.36) | Buy |
Akero Therapeutics Technical Analysis
Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 54.00 while AKRO 8-day simple moving average is 35.66, which is a Buy signal.
-
The stock price of AKRO is 54.00 while Akero Therapeutics 20-day SMA is 29.67, which makes it a Buy.
-
Akero Therapeutics 50-day simple moving average is 29.97 while AKRO share price is 54.00, making it a Buy technically.
-
AKRO stock price is 54.00 and Akero Therapeutics 200-day simple moving average is 26.38, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a BuyThe current Akero Therapeutics [AKRO] share price is $54.00. The Score for AKRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
3.8B
Price in USD:
54.00
Share Volume:
3.6M
Akero Therapeutics 52-Week Range
52-Week High:
58.40
52-Week Low:
15.32
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?The Akero Therapeutics stock price is 54.00 USD today.
-
Will AKRO stock go up or go down?Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akero Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 54.00 while AKRO 8-day exponential moving average is 39.78, which is a Buy signal.
-
The stock price of AKRO is 54.00 while Akero Therapeutics 20-day EMA is 32.93, which makes it a Buy.
-
Akero Therapeutics 50-day exponential moving average is 30.49 while AKRO share price is 54.00, making it a Buy technically.
-
AKRO stock price is 54.00 and Akero Therapeutics 200-day simple moving average is 28.24, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and an increase next year of $0.08 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
-
AKRO Moving Average Covergence Divergence (MACD) indicator is 4.24, suggesting Akero Therapeutics is a Buy
-
Akero Therapeutics Relative Strength Index (RSI) is 85.85, which suggest Akero Therapeutics is overbought
-
The Bollinger Bands (25) for Akero Therapeutics is (20.76 - 38.18), which suggest Akero Therapeutics is a Buy
-
The Bollinger Bands (100) for Akero Therapeutics is (24.88 - 34.36), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.